Spectrum of mutations in genes associated with familial colorectal cancer syndrome (MLH1, MSH2, PMS2, MSH6, and APC): A not so common hereditary cancer syndrome in Indian population
Tóm tắt
Incidence of colorectal cancer (CRC) is lower in India than in other parts of the world. Approximately 5% to 10% of CRC is inherited. Hereditary non-polyposis colorectal cancer (HNPCC) syndrome and familial adenomatous polyposis (FAP) syndrome are the two known familial cancer syndromes of gastrointestinal tract, which occur due to inherited genetic predisposition. Not much is known about the molecular profile of families with inherited CRC syndromes seen in Indian population. At our institute, we have been providing genetic testing and counseling service to all the families referred to us with suspicion of inherited cancer predisposition syndrome. We analyzed 36 suspected families at our clinic. Personal and family history of cancer was obtained from the proband and appropriate genetic testing was performed in 19 patients (13 with HNPCC, 5 with FAP, and 1 with Cowden syndrome). We present here our experience and spectrum of pathogenic variants observed in this patient cohort and review on published studies describing molecular profile of Indian patients with CRC syndromes.
Tài liệu tham khảo
“Fact Sheets by Population-CRC India ASRs.” [Online]. Available: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed 5 Aug 2018.
Patil PS, Saklani A, Gambhire P, et al. Colorectal cancer in India: an audit from a tertiary center in a low prevalence area. Indian J Surg Oncol. 2017;8:484–90.
Pal M. Proportionate increase in incidence of colorectal cancer at an age below 40 years: an observation. J Cancer Res Ther. 2006;2:97–9.
Maharaj R, Shukla PJ, Sakpal SV, et al. The impact of hereditary colorectal cancer on the Indian population. Indian J Cancer. 2014;51:538–41.
Patel SG, Ahnen DJ. Familial colon cancer syndromes: an update of a rapidly evolving field. Curr Gastroenterol Rep. 2012;14:428–38.
Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–8.
Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116:1453–6.
Ishimura N, Yamasawa K, Karim Rumi MA, et al. BRAF and K-ras gene mutations in human pancreatic cancers. Cancer Lett. 2003;199:169–73.
Hegde MR, Roa BB. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC). Curr Protoc Hum Genet. 2009;Chapter 10:Unit 10.12. https://doi.org/10.1002/0471142905.hg1012s61.
Torrezan GT, da Silva FC, Santos EM, et al. Mutational spectrum of the APC and MUTYH genes and genotype-phenotype correlations in Brazilian FAP, AFAP, and MAP patients. Orphanet J Rare Dis. 2013;8:54.
Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–36.
Borràs E, Pineda M, Brieger A, et al. Comprehensive functional assessment of MLH1 variants of unknown significance. Hum Mutat. 2012;33:1576–88.
Takahashi M, Shimodaira H, Andreutti-Zaugg C, et al. Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res. 2007;67:4595–604.
Loconte DC, Patruno M, Lastella P, et al. A rare MSH2 mutation causes defective binding to hMSH6, normal hMSH2 staining, and loss of hMSH6 at advanced cancer stage. Hum Pathol. 2014;45:2162–7.
Bashyam MD, Kotapalli V, Raman R, et al. Evidence for presence of mismatch repair gene expression positive Lynch syndrome cases in India. Mol Carcinog. 2015;54:1807–14.
Rajkumar T, Soumittra N, Pandey D, et al. Mutation analysis of hMSH2 and hMLH1 in colorectal cancer patients in India. Genet Test. 2004;8:157–62.
Khan N, Lipsa A, Arunachal G, et al. Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian familial adenomatous polyposis cohort. Sci Rep. 2017;7:2214.
Rajender S, Pooja S, Kumar MV, et al. R659X mutation in the MLH1 gene in hereditary non-polyposis colorectal cancer (HNPCC) in an Indian extended family. Indian J Med Res. 2010;131:64–70.
Ponti G, Castellsagué E, Ruini C, et al. Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. Clin Genet. 2015;87:507–16.